Tissue Regenix Group
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Tissue Regenix Group generated cash of $1,040,000, which is more than the previous year. Cash used in financing activities reached the amount of -$1,512,000 last year. Net change in cash is therefore -$1,299,000.
Cash Flow
| 2012 | -2.12M | 32K | 24.22M |
|---|---|---|---|
| 2016 | -12.64M | -696.43K | 27.08M |
| 2016 | -10.69M | -1.03M | 0 |
| 2017 | -9.73M | -20.16M | 37.99M |
| 2018 | -6.76M | -1.97M | 4K |
| 2019 | -7.04M | -651K | 2.28M |
| 2020 | -5.47M | -1.37M | 14.01M |
| 2021 | -2.44M | -1.48M | 144.69K |
| 2022 | -1.40M | -884.89K | 1.10M |
| 2023 | 1.04M | -837K | -1.51M |
TRX.L Cash Flow Statement (2012 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 5.94M | 5.69M | 9.55M | 2.38M | 7.81M | 16.42M | 8.17M | 10.25M | 14.60M | 5.88M |
Operating activities | ||||||||||
Net income | -1.66M | -2.18M | -3.48M | -9.70M | -6.97M | -8.18M | -9.22M | -10.67M | -14.58M | -2.68M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 785.96K | 921.43K | 793.27K | 762K | 1.04M | 1.17M | 707K | 328.36K | 348.92K | 62K |
Stock-based compensation expense | 342K | 249K | 110K | 0 | -191.43K | 0 | 40.54K | 0 | 193.69K | 122K |
| Deferred income tax benefit | 342K | 249K | 110K | 0 | -191.43K | 0 | 40.54K | 0 | 193.69K | 122K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 841.69K | -569.90K | -372.28K | -11K | 1.07M | -1.18M | -783K | -90K | 0 | 0 |
Inventories | 411.04K | -944.16K | -83.61K | -2.88M | -1.85M | 542K | -503K | -597K | -42.72K | 0 |
Accounts payable | -1.47M | 1.01M | 115.61K | -46K | -1.56M | 156K | 38K | 106K | 0 | 0 |
Cash generated by operating activities | 1.04M | -1.40M | -2.44M | -5.47M | -7.04M | -6.76M | -9.73M | -10.69M | -12.64M | -2.12M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -323.96K | -884.89K | -1.48M | -1.37M | -651K | -406K | -223K | -1.03M | -1.01M | -30K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | -1.56M | -19.94M | 0 | 12.81K | 0 |
Cash generated by investing activities | -837K | -884.89K | -1.48M | -1.37M | -651K | -1.97M | -20.16M | -1.03M | -696.43K | 32K |
Financing activities | ||||||||||
Common Stock Issued | 74K | 9K | 0 | 13.75M | 1.31K | 4K | 51.34M | 0 | 27.08M | 25.00M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -238K | 1.38M | -437.72K | -504K | 2.28M | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | -1.51M | 1.10M | 144.69K | 14.01M | 2.28M | 4K | 37.99M | 0 | 27.08M | 24.22M |
Net Change In Cash | -1.29M | -746.06K | -3.85M | 7.17M | -5.43M | -8.60M | 8.24M | -2.08M | 13.74M | 22.13M |
Cash at end of period | 4.65M | 4.94M | 5.69M | 9.55M | 2.38M | 7.81M | 16.42M | 8.17M | 28.35M | 28.02M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |